• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

21
17
17
12
8

COUNTRY

16
3
2
1
1

CATEGORIES

  • 28
  • 10
  • 8
  • 6
  • 6
  • 4
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

28
33
35
68

PUBLISHED

1
4
13
68

PRODUCT TYPE

49
19

Search "Hologic Inc-Deals & Alliances Report" returned 68 results.

PRODUCT TITLE
Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] - Product Thumbnail Image

Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements]

The Pharma and Biotech M&A Trends 2009-2014 report provides comprehensive understanding and unprecedented access to the merger and acquisition agreements entered into by the worlds leading biopharma...

July 2014
FROM

Hologic, Inc. - SWOT, Strategy and Corporate Finance Report

Hologic, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and...

June 2013
FROM

Hologic, Inc. - Strategy and SWOT Report

Hologic, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings...

March 2014
FROM

Hologic, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain...

June 2014
FROM
Biomarkers, Tests and Trends for Drug R&D Biomarkers, Tests and Trends for Drug R&D - Product Thumbnail Image

Biomarkers, Tests and Trends for Drug R&D

This report is about the world market for biomarkers and tests used for drug R&D The study reviews and analyzes the market by examining biomarker related drug R&D spending, trends, major diseases, applications,...

February 2010
FROM
Molecular Diagnostics - Global Strategic Business Report Molecular Diagnostics - Global Strategic Business Report - Product Thumbnail Image

Molecular Diagnostics - Global Strategic Business Report

This report analyzes the worldwide markets for Molecular Diagnostics in US$ million by the following Product Segments: Infectious Disease Testing, Pharmacogenomics, and Cancer Screening The report provides...

November 2012
FROM
Hologic Inc-Detailed Product Pipeline Hologic Inc-Detailed Product Pipeline - Product Thumbnail Image

Hologic Inc-Detailed Product Pipeline

Hologic Inc-Detailed Product Pipeline Report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the...

March 2011
FROM
Hologic Inc-Detailed Product Pipeline Hologic Inc-Detailed Product Pipeline - Product Thumbnail Image

Hologic Inc-Detailed Product Pipeline

Hologic Inc-Detailed Product Pipeline Report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the...

March 2011
FROM
Prenatal Diagnostics - Global Strategic Business Report Prenatal Diagnostics - Global Strategic Business Report - Product Thumbnail Image

Prenatal Diagnostics - Global Strategic Business Report

This report analyzes the worldwide markets for Prenatal Diagnostics in US$ Million The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America,...

July 2012
FROM
SenoRx, Inc. - Strategic SWOT Analysis Review SenoRx, Inc. - Strategic SWOT Analysis Review - Product Thumbnail Image

SenoRx, Inc. - Strategic SWOT Analysis Review

SenoRx, Inc. - Strategic SWOT Analysis Review Summary SenoRx, Inc. (SenoRx) is a medical device company. The company carries out design, development, manufacturing and marketing of medical devices...

September 2012
FROM
Germany Diagnostic Imaging Investment Opportunities, Analysis and Forecasts to 2012 Germany Diagnostic Imaging Investment Opportunities, Analysis and Forecasts to 2012 - Product Thumbnail Image

Germany Diagnostic Imaging Investment Opportunities, Analysis and Forecasts to 2012

Germany Diagnostic Imaging Investment Opportunities, Analysis and Forecasts to 2012 Summary This report is an essential source for in-depth information and data relating to the Germany diagnostic...

February 2009
FROM
France Diagnostic Imaging Investment Opportunities, Analysis and Forecasts to 2012 France Diagnostic Imaging Investment Opportunities, Analysis and Forecasts to 2012 - Product Thumbnail Image

France Diagnostic Imaging Investment Opportunities, Analysis and Forecasts to 2012

France Diagnostic Imaging Investment Opportunities, Analysis and Forecasts to 2012 Summary This report is an essential source for in-depth information and data relating to the France diagnostic imaging...

February 2009
FROM
South and Central America In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 South and Central America In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 - Product Thumbnail Image

South and Central America In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

South and Central America In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 Summary This report is an essential source for in-depth information and data relating to South...

September 2009
FROM
Brazil In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 Brazil In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 - Product Thumbnail Image

Brazil In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Brazil In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 Summary This report is an essential source for in-depth information and data relating to Brazil In vitro diagnostic...

September 2009
FROM
Mexico In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 Mexico In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 - Product Thumbnail Image

Mexico In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Mexico In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 Summary This report is an essential source for in-depth information and data relating to Mexico In vitro diagnostic...

September 2009
FROM
SenoRx, Inc. - Financial and Strategic SWOT Analysis Review SenoRx, Inc. - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

SenoRx, Inc. - Financial and Strategic SWOT Analysis Review

SenoRx, Inc. - Financial and Strategic SWOT Analysis Review Summary SenoRx, Inc. (SenoRx) is a medical device company engaged in developing, manufacturing and selling of medical devices for the diagnosis...

September 2011
FROM
Third Wave Technologies, Inc. - Strategic SWOT Analysis Review Third Wave Technologies, Inc. - Strategic SWOT Analysis Review - Product Thumbnail Image

Third Wave Technologies, Inc. - Strategic SWOT Analysis Review

Third Wave Technologies, Inc. - Strategic SWOT Analysis Review Summary Third Wave Technologies, Inc. (Third Wave) is a molecular diagnostics company. It is principally engaged in developing and selling...

September 2011
FROM

iCAD, Inc. (ICAD) - Financial and Strategic SWOT Analysis Review

iCAD, Inc. (ICAD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData...

June 2014
FROM

Gen-Probe Incorporated - Strategic SWOT Analysis Review

Gen-Probe Incorporated - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed...

February 2014
FROM
Industry Report Card: Medicare Cuts Loom As A Senior Factor in U.S. Health Care Company Ratings Oct 11 Industry Report Card: Medicare Cuts Loom As A Senior Factor in U.S. Health Care Company Ratings Oct 11 - Product Thumbnail Image

Industry Report Card: Medicare Cuts Loom As A Senior Factor in U.S. Health Care Company Ratings Oct 11

Abstract Third-party funding of essential care, along with continued high margins for patented medical treatments, has protected many U.S. for-profit health care industry participants from the difficulties...

October 2011
Loading Indicator